EVOLUTION OF THE LDL RECEPTOR CONCEPT–FROM CULTURED CELLS TO INTACT ANIMALS *

The initial observations in cultured fibroblasts made six years ago allowed the formulation of a series of hypotheses concerning LDL metabolism in tissues of animals and man. The most important of these hypotheses was that a large fraction of LDL was removed from plasma by a specific receptor-mediated uptake mechanism whose function was to supply cholesterol to extrahepatic cells. This hypothesis is strongly supported by genetic observations in patients with familial hypercholesterolemia and by studies of the four model systems discussed above. These studies by no means solve all of the important questions about LDL metabolism. We still need to know which tissues take up the most LDL; we need to know how much LDL is cleared by the liver and whether this clearance involves the same LDL receptor that operates in extra-hepatic cells; we need to know the mechanism for the clearance of the one-half to two-thirds of LDL that leaves the plasma by receptor-independent pathways; and finally we need to know how an abnormal accumulation of LDL in the plasma leads to the deposition of cholesterol in scavenger cells and produces atherosclerosis.

[1]  A. Soutar,et al.  Evidence for Defect of Receptor-Mediated Low-Density Lipoprotein Catabolism in Familial Hypercholesterolaemia In Vivo , 1980 .

[2]  R. Mahley,et al.  Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Brown,et al.  Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. , 1979, The Journal of biological chemistry.

[4]  C. Packard,et al.  Receptor-mediated low density lipoprotein catabolism in man. , 1979, Journal of lipid research.

[5]  S. Grundy,et al.  Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. , 1979, The Journal of clinical investigation.

[6]  M. Brown,et al.  Separate mechanisms for the uptake of high and low density lipoproteins by mouse adrenal gland in vivo. , 1979, The Journal of biological chemistry.

[7]  M. Brown,et al.  Low density lipoprotein receptors in bovine adrenal cortex. II. Low density lipoprotein binding to membranes prepared from fresh tissue. , 1979, Endocrinology.

[8]  M. Brown,et al.  Low density lipoprotein receptors in bovine adrenal cortex. I. Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured adrenocortical cells. , 1979, Endocrinology.

[9]  M. Brown,et al.  Familial hypercholesterolemia: model for genetic receptor disease. , 1979, Harvey lectures.

[10]  M. Brown,et al.  Receptor-mediated uptake of lipoprotein-cholesterol and its utilization for steroid synthesis in the adrenal cortex. , 1979, Recent progress in hormone research.

[11]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[12]  J. Dietschy,et al.  Relative importance of high and low density lipoproteins in the regulation of cholesterol synthesis in the adrenal gland, ovary, and testis of the rat. , 1978, The Journal of biological chemistry.

[13]  M. Brown,et al.  Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. , 1978, Blood.

[14]  R. Davis,et al.  Pharmacologically induced hypolipidemia. The ethinyl estradiol-treated rat. , 1978, Atherosclerosis.

[15]  M. Brown,et al.  High levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in the ovary of the pregnant rabbit. , 1978, The Journal of biological chemistry.

[16]  M. Brown,et al.  Characterization of the low density lipoprotein receptor in membranes prepared from human fibroblasts. , 1978, The Journal of biological chemistry.

[17]  J. Fryns,et al.  PRENATAL DIAGNOSIS OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA Expression of a Genetic Receptor Disease in Utero , 1978, The Lancet.

[18]  K.,et al.  Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia. , 1978, The Journal of clinical investigation.

[19]  M. Brown,et al.  Atherosclerosis: the low-density lipoprotein receptor hypothesis. , 1977, Metabolism: clinical and experimental.

[20]  M. Brown,et al.  Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured mouse adrenal cells. , 1977, The Journal of biological chemistry.

[21]  J. Dietschy,et al.  Regulation of sterol synthesis in 15 tissues of rat. II. Role of rat and human high and low density plasma lipoproteins and of rat chylomicron remnants. , 1977, The Journal of biological chemistry.

[22]  D. Bilheimer,et al.  Regulation of cholesterol synthesis by low density lipoprotein in isolated human lymphocytes , 1977, The Journal of experimental medicine.

[23]  T. Spinks,et al.  Non-stedy-state studies of low-density-liproprotein turnover in familial hypercholesterolaemia. , 1977, Clinical science and molecular medicine.

[24]  M. Brown,et al.  Lipoprotein-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesteryl ester metabolism in the adrenal gland of the rat. , 1977, The Journal of biological chemistry.

[25]  Richard G. W. Anderson,et al.  Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts , 1977, Cell.

[26]  M. Brown,et al.  Specific, saturable, and high affinity binding of 125I-low density lipoprotein to glass beads. , 1977, Biochemical and biophysical research communications.

[27]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[28]  D. Bilheimer,et al.  Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. , 1976, The Journal of clinical investigation.

[29]  J. Goldstein,et al.  Heterozygous familial hypercholesterolemia: Failure of normal allele to compensate for mutant allele at a regulated genetic locus , 1976, Cell.

[30]  H. G. Morgan,et al.  Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients. , 1976, Metabolism: clinical and experimental.

[31]  M. Brown,et al.  Evidence for regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Brown,et al.  Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells from a familial hypercholesterolemia homozygote. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Goldstein,et al.  Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans , 1976, Cell.

[34]  M. Brown,et al.  Receptor-mediated control of cholesterol metabolism. , 1976, Science.

[35]  S. Grundy,et al.  Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. , 1975, The Journal of clinical investigation.

[36]  J. Goldstein,et al.  Regulation of the activity of the low density lipoprotein receptor in human fibroblasts , 1975, Cell.

[37]  M. Brown,et al.  Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339. , 1975, The Journal of biological chemistry.

[38]  M. Brown,et al.  Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Simons,et al.  The metabolism of the apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinaemia in the homozygous form. , 1975, Atherosclerosis.

[40]  M. Brown,et al.  Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Brown,et al.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[42]  M. Brown,et al.  Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Brown,et al.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Levy,et al.  The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. , 1972, The Journal of clinical investigation.

[45]  H. Eder,et al.  Effects of high sucrose diets and 4-aminopyrazolopyrimidine on serum lipids and lipoproteins in the rat. , 1971, Journal of lipid research.

[46]  Wilson Jd,et al.  Regulation of cholesterol metabolism. 3. , 1970 .

[47]  N. Myant.  The regulation of cholesterol metabolism. , 1968, Postgraduate medical journal.